Avalon Pharma Renews SAR50 Million Credit Facility

01:28 AM EDT, 08/20/2026 (MT Newswires) -- Middle East Pharmaceutical Industries Co. (SASE:4016), d/b/a Avalon Pharma, renewed its credit facilities deal worth 50 million Saudi riyals with Alinma Bank. The Sharia-compliant financing, valid for one year, will fund the pharmaceutical company's working capital and assets, according to a Thursday release.